Embolism, Paradoxical - 5 Studies Found
Recruiting |
: PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism :
: 2005-09-09 :
|
Withdrawn |
: Patients With Patent Foramen Ovale and Endocardial Device Leads on Apixaban for Prevention of Paradoxical Emboli :
: 2015-02-27 :
|
Withdrawn |
: Paradigm I Clinical Trial: Study of the PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemia Attack or Paradoxical Embolism : Patent Foramen Ovale : 2005-09-12 : Device: PFX Closure System |
Available |
: PFO ACCESS Registry :
: 2007-12-21 : Device: Device closure with the AMPLATZER PFO Occluder Device closure with the AMPLATZER PFO Occluder |
Available |
: Evaluation of the STARFlex® Septal Closure System in Patients With a Stroke or TIA Due to the Possible Passage of a Clot of Unknown Origin Through a Patent Foramen Ovale (PFO) :
: |